SBC Medical Group Holdings Incorporated Operating Income
SBC Medical Group Holdings Incorporated (SBC) reported Operating Income of $18.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated operating income (loss) for the quarter ending 2026-06-30 was $18.96M, a 30.28% increase year-over-year.
- SBC Medical Group Holdings Incorporated operating income (loss) for the quarter ending 2026-03-31 was $17.72M, a 26.78% decline year-over-year.
- SBC Medical Group Holdings Incorporated operating income (loss) for the quarter ending 2025-12-31 was $12.85M, a 172.36% increase year-over-year.
- SBC Medical Group Holdings Incorporated operating income (loss) for the quarter ending 2025-09-30 was $15.88M, a 14.79% increase year-over-year.
- SBC Medical Group Holdings Incorporated operating income (loss) for fiscal 2025 was $67.49M, a 4.01% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated operating income (loss) for fiscal 2024 was $70.30M, a 0.50% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated operating income (loss) for fiscal 2023 was $70.66M.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 7 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 10 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.96M 10-Q · filed 2026-08-13 | $36.68M 10-Q · filed 2026-08-13 | $49.53M derived: sum of 3 quarters · filed 2026-08-13 | $65.41M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2026-03-31 | $17.72M 10-Q · filed 2026-05-14 | $30.57M derived: sum of 2 quarters · filed 2026-05-14 | $46.45M derived: sum of 3 quarters · filed 2026-05-14 | $61.00M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-12-31 | $12.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $28.73M derived: sum of 2 quarters · filed 2026-03-27 | $43.28M derived: sum of 3 quarters · filed 2026-08-13 | $67.49M 10-K · filed 2026-03-27 | ||||||||
| 2025-09-30 | $15.88M 10-Q · filed 2025-11-14 | $30.44M derived: sum of 2 quarters · filed 2026-08-13 | $54.64M 10-Q · filed 2025-11-14 | $59.36M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-06-30 | $14.55M 10-Q · filed 2026-08-13 | $38.76M 10-Q · filed 2026-08-13 | $43.47M derived: sum of 3 quarters · filed 2026-08-13 | $57.31M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-03-31 | $24.20M 10-Q · filed 2026-05-14 | $28.92M derived: sum of 2 quarters · filed 2026-05-14 | $42.75M derived: sum of 3 quarters · filed 2026-05-14 | $70.04M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||
| 2024-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $18.55M derived: sum of 2 quarters · filed 2026-03-27 | $45.84M derived: sum of 3 quarters · filed 2026-03-27 | $70.30M 10-K · filed 2026-03-27 | ||||||||
| 2024-09-30 | $13.83M 10-Q · filed 2025-11-14 | $41.13M derived: sum of 2 quarters · filed 2025-11-14 | $65.59M 10-Q · filed 2025-11-14 | $89.58M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | $27.29M 10-Q · filed 2025-08-13 | -$501.72K 10-Q · filed 2024-08-16 | $51.75M 10-Q · filed 2025-08-13 | -$1.01M 10-Q · filed 2024-08-16 | $75.74M derived: sum of 3 quarters · filed 2025-08-13 | $95.76M derived: sum of 4 quarters · filed 2025-08-13 | ||||||
| 2024-03-31 | $24.46M 10-Q · filed 2025-05-15 | -$504.67K 10-Q · filed 2024-05-20 | $48.45M derived: sum of 2 quarters · filed 2025-05-15 | $68.47M derived: sum of 3 quarters · filed 2025-05-15 | $68.00M derived: sum of 4 quarters · filed 2025-05-15 | |||||||
| 2023-12-31 | $23.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $44.01M derived: sum of 2 quarters · filed 2025-03-28 | $43.54M derived: sum of 3 quarters · filed 2025-03-28 | $70.66M 10-K · filed 2025-03-28 | -$1.77M 10-K · filed 2024-03-19 | |||||||
| 2023-09-30 | $20.02M 10-Q · filed 2024-11-13 | -$323.36K 10-Q · filed 2023-11-14 | $19.55M derived: sum of 2 quarters · filed 2024-11-13 | $46.67M 10-Q · filed 2024-11-13 | -$1.19M 10-Q · filed 2023-11-14 | |||||||
| 2023-06-30 | -$473.37K 10-Q · filed 2024-08-16 | -$861.82K 10-Q · filed 2024-08-16 | ||||||||||
| 2023-03-31 | -$388.45K 10-Q · filed 2024-05-20 | |||||||||||
| 2022-12-31 | -$543.70K 10-K · filed 2024-03-19 | |||||||||||
| 2022-09-30 | -$303.62K 10-Q · filed 2023-11-14 | -$304.90K derived: sum of 2 quarters · filed 2023-11-14 | -$305.24K 10-Q · filed 2023-11-14 | |||||||||
| 2022-06-30 | -$1.28K 10-Q · filed 2023-08-14 | -$1.62K 10-Q · filed 2023-08-14 | ||||||||||
| 2022-03-31 | -$339.00 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |